Mirum Pharmaceuticals Files 8-K/A Amendment
Ticker: MIRM · Form: 8-K/A · Filed: Apr 8, 2026 · CIK: 0001759425
Sentiment: neutral
Topics: amendment, exhibits, financial-statements
TL;DR
Mirum Pharma filed an 8-K/A amendment on 4/8/26, adding exhibits and financial statement info.
AI Summary
Mirum Pharmaceuticals, Inc. filed an amendment (8-K/A) on April 8, 2026, to its previously filed report. This amendment primarily concerns Item 9.01, which relates to Financial Statements and Exhibits. The filing includes updated or additional exhibits, such as EX-23.1, EX-99.1, and EX-99.2, alongside the iXBRL formatted 8-K/A document.
Why It Matters
This amendment indicates a procedural update or addition of required documentation to a previous filing, potentially related to financial reporting or corporate events.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report, primarily containing exhibits and financial statement information, which typically does not represent new material risks.
Key Numbers
- 0001759425-26-000021 — SEC Accession Number (Unique identifier for this specific filing)
Key Players & Entities
- Mirum Pharmaceuticals, Inc. (company) — Filer of the 8-K/A amendment
- 0001759425 (company) — CIK number for Mirum Pharmaceuticals, Inc.
- 2026-04-08 (date) — Filing date of the 8-K/A amendment
- 2026-01-23 (date) — Period of report for the filing
FAQ
What specific financial statements or exhibits were added or amended in this 8-K/A filing?
The filing includes exhibits EX-23.1, EX-99.1, and EX-99.2, along with the iXBRL formatted 8-K/A document, suggesting these are the primary additions or amendments.
What is the purpose of an 8-K/A filing?
An 8-K/A filing is an amendment to a previously filed 8-K report, used to correct or supplement information previously disclosed.
When was the original report that this 8-K/A amends likely filed?
While not explicitly stated, the 'Period of Report' is 2026-01-23, and the amendment was filed on 2026-04-08, suggesting the original report was filed around or before January 23, 2026.
What is Mirum Pharmaceuticals, Inc.'s primary business according to the filing details?
The SIC code 2834 indicates the company is in Pharmaceutical Preparations.
Where is Mirum Pharmaceuticals, Inc. located?
The company's mailing and business address is 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA 94404.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 8, 2026 regarding Mirum Pharmaceuticals, Inc. (MIRM).